Safety and efficacy of sacubitril/valsartan in patients with heart failure with mildly reduced or preserved EF after a worsening heart failure event based on diuretic use in PARAGLIDE-HF
12 May 2024 (14:00 - 14:45)
Organised by: 
Abstract
Slides
About the speaker
Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
6 More presentations in this session
Doctor M. Groba Marco (Las Palmas de Gran Canaria, ES)
Mrs A. Robles Mezcua (Malaga, ES)
Doctor F. Ballacci (Udine, IT)
Doctor H. Unlugenc (Izmir, TR)
Access the full session
The Event
Heart Failure 2024
12 May 2024
14:00 CET
You may be interested in
Congress Presentation
